Grimes & Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Grimes & Company’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.9M	Buy	340,013 +27,976	+9%	+$4.16M	1.17%	16
2026 Q1	$45.7M	Sell	312,037 -87,844	-22%	-$13.5M	1.27%	14
2025 Q4	$61.9M	Buy	399,881 +238,562	+148%	+$35.7M	1.48%	13
2025 Q3	$22.5M	Buy	161,319 +16,925	+12%	+$2.29M	0.55%	35
2025 Q2	$19.5M	Sell	144,394 -138,601	-49%	-$18.7M	0.53%	37
2025 Q1	$41.3M	Buy	282,995 +223,620	+377%	+$32.5M	1.28%	15
2024 Q4	$8.17M	Sell	59,375 -157,516	-73%	-$23.1M	0.24%	81
2024 Q3	$33.4M	Buy	216,891 +8,130	+4%	+$1.23M	0.9%	19
2024 Q2	$30.4M	Sell	208,761 -86,059	-29%	-$12.3M	0.91%	23
2024 Q1	$43.6M	Buy	294,820 +9,128	+3%	+$1.31M	1.34%	15
2023 Q4	$39M	Sell	285,692 -87,100	-23%	-$11.3M	1.29%	16
2023 Q3	$48M	Sell	372,792 -20,155	-5%	-$2.68M	1.86%	12
2023 Q2	$52.2M	Buy	392,947 +3,268	+0.8%	+$431K	1.85%	13
2023 Q1	$50.4M	Buy	389,679 +21,400	+6%	+$2.8M	2.07%	10
2022 Q4	$50M	Sell	368,279 -50,573	-12%	-$6.7M	2.11%	8
2022 Q3	$50.7M	Buy	418,852 +166,501	+66%	+$21.4M	2.65%	7
2022 Q2	$32.4M	Sell	252,351 -165,485	-40%	-$21.7M	1.63%	7
2022 Q1	$57.2M	Buy	417,836 +146,998	+54%	+$19.5M	2.99%	7
2021 Q4	$38.2M	Sell	270,838 -38,967	-13%	-$5.17M	1.75%	12
2021 Q3	$39.4M	Buy	309,805 +8,341	+3%	+$1.1M	1.72%	14
2021 Q2	$38M	Buy	301,464 +32,465	+12%	+$3.98M	1.65%	15
2021 Q1	$31.4M	Buy	268,999 +14,555	+6%	+$1.68M	1.51%	15
2020 Q4	$28.9M	Buy	254,444 +18,554	+8%	+$2.03M	1.5%	15
2020 Q3	$24.9M	Buy	235,890 +18,749	+9%	+$1.97M	1.59%	14
2020 Q2	$21.7M	Buy	217,141 +185,184	+579%	+$18.3M	1.51%	15
2020 Q1	$2.83M	Sell	31,957 -184,828	-85%	-$18M	0.26%	74
2019 Q4	$22.1M	Buy	216,785 +22,522	+12%	+$2.17M	1.45%	15
2019 Q3	$17.5M	Buy	194,263 +190,874	+5,632%	+$17.4M	1.25%	18
2019 Q2	$314K	Buy	3,389 +85	+3%	+$7.64K	0.02%	201
2019 Q1	$303K	Buy	3,304 +668	+25%	+$60.2K	0.02%	198
2018 Q4	$228K	Hold	2,636	–	–	0.02%	208
2018 Q3	$251K	Sell	2,636 -106	-4%	-$9.58K	0.02%	209
2018 Q2	$229K	Buy	+2,742	New	+$227K	0.02%	212
2018 Q1	–	Sell	-2,457	Closed	-$203K	–	253
2017 Q4	$203K	Hold	2,457	–	–	0.02%	207
2017 Q3	$201K	Buy	+2,457	New	+$197K	0.02%	195
2016 Q4	–	Sell	-2,862	Closed	-$206K	–	217
2016 Q3	$206K	Sell	2,862 -534	-16%	-$39.3K	0.03%	184
2016 Q2	$244K	Buy	3,396 +440	+15%	+$31K	0.03%	175
2016 Q1	$200K	Buy	+2,956	New	+$198K	0.03%	188
2015 Q3	–	Sell	-3,335	Closed	-$248K	–	210
2015 Q2	$248K	Buy	+3,335	New	+$247K	0.03%	165

Other funds holding XLV

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

RIG

RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return

Greenwood Gearhart Fayetteville, Arkansas $2.15B AUM 25.78% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Grimes & Company's XLV Position: Q2 2026 in Review

Grimes & Company increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 9% in Q2 2026, buying an estimated $4.16M and bringing the position to 340,013 shares worth $53.9M. The position accounts for 1.17% of the portfolio, ranked #16.

Grimes & Company first reported a position in XLV in Q2 2015 and has held it in 39 quarters since. The position peaked at $61.9M in Q4 2025. 854 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Grimes & Company held 340,013 shares of State Street Health Care Select Sector SPDR ETF worth $53.9M as of Q2 2026.
Grimes & Company bought 27,976 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $4.16M.
State Street Health Care Select Sector SPDR ETF made up 1.17% of Grimes & Company's portfolio in Q2 2026, its #16 holding.
Grimes & Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2015 and has held it in 39 quarters since.
Grimes & Company's State Street Health Care Select Sector SPDR ETF position peaked at $61.9M in Q4 2025.
854 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.